Novo Holdings A/S

Overview

• HeadquartersG7¹

See how the biggest companies compare on our leaderboards

Corporate structure

Novo Holdings A/S sits at the top of its group. 33 entities, 4 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (32 companies). Each entity in the chart links to its source.

Filings

32 filings to the SEC since October 2021: 32 other. The latest 20:

1. Aug 31, 2026N-PX EDGAR
2. Aug 14, 202613F-HR EDGAR
3. May 15, 202613F-HR EDGAR
4. Feb 17, 202613F-HR EDGAR
5. Nov 14, 202513F-HR EDGAR
6. Aug 29, 2025N-PX EDGAR
7. Aug 14, 202513F-HR EDGAR
8. May 15, 202513F-HR EDGAR
9. Feb 14, 202513F-HR EDGAR
10. Oct 24, 202413F-HR EDGAR
11. Sep 11, 2024144 EDGAR
12. Aug 23, 2024N-PX EDGAR
13. Aug 20, 202413F-HR/A EDGAR
14. Aug 14, 202413F-HR EDGAR
15. Jul 25, 2024144 EDGAR
16. May 15, 202413F-HR EDGAR
17. May 10, 2024144 EDGAR
18. Feb 14, 202413F-HR EDGAR
19. Feb 9, 2024144 EDGAR
20. Nov 14, 202313F-HR EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Stakes it holds

Novo Holdings A/S has told the SEC it owns more than 5% of 32 companies, latest first (Schedules 13D and 13G).

• Avalyn Pharma Inc.SCHEDULE 13G Aug 14, 2026²
• Hemab Therapeutics Holdings, Inc.SCHEDULE 13G Aug 14, 2026³
• Obsidian Therapeutics, Inc.SCHEDULE 13G Aug 10, 2026⁴
• MapLight Therapeutics, Inc.SCHEDULE 13D/A Nov 4, 2025 to Jul 31, 2026⁵
• LanzaTech Global, Inc.SCHEDULE 13G/A Feb 17, 2023 to May 15, 2026⁶
• Edgewise Therapeutics, Inc.SCHEDULE 13D/A Sep 16, 2022 to Apr 27, 2026⁷
• 4D Molecular Therapeutics, Inc.SCHEDULE 13G/A Oct 20, 2025 to Feb 17, 2026⁸
• EvotecSCHEDULE 13G/A Feb 2, 2022 to Feb 17, 2026⁹
• IO Biotech, Inc.SCHEDULE 13D/A Nov 10, 2021 to Jan 23, 2026¹⁰
• Zenas BioPharma, Inc.SCHEDULE 13G/A Apr 1, 2025 to Nov 14, 2025¹¹
• Damora Therapeutics, Inc.SCHEDULE 13D/A Sep 30, 2022 to Oct 9, 2025¹²
• ArriVent BioPharma, Inc.SCHEDULE 13G/A Feb 14, 2025 to Aug 14, 2025¹³
• Exscientia plcSC 13G/A Feb 2, 2022 to Nov 22, 2024¹⁴
• SPRUCE BIOSCIENCES, INC.SC 13D/A Nov 22, 2021 to Mar 28, 2024¹⁵
• LAVA Therapeutics NVSC 13D/A Sep 30, 2022 to Mar 7, 2024¹⁶
• RallybioSC 13G/A Nov 17, 2022 to Jan 2, 2024¹⁷
• Lexeo Therapeutics, Inc.SC 13G/A Nov 24, 2023 to Dec 15, 2023¹⁸
• OnKure Therapeutics, Inc.SC 13D/A Jan 27, 2022 to Dec 15, 2023¹⁹
• Cyteir Therapeutics, Inc.SC 13D/A Dec 20, 2021 to Aug 3, 2023²⁰
• Disc Medicine, Inc.SC 13G/A Jan 3, 2023 to Jun 28, 2023²¹
• Galera Therapeutics, Inc.SC 13G/A Feb 2, 2022 to Jun 28, 2023²²
• VectivBio Holding AGSC 13G/A Feb 2, 2023 to May 26, 2023²³
• Bolt Biotherapeutics, Inc.SC 13D/A Nov 22, 2021 to Jan 4, 2023²⁴
• Arcellx, Inc.SC 13G/A Feb 9, 2022 to Dec 12, 2022²⁵
• MINERVA SURGICAL INCSC 13G/A Oct 27, 2021 to Nov 3, 2022²⁶
• Milestone Pharmaceuticals Inc.SC 13D/A Sep 26, 2022 to Oct 24, 2022²⁷
• Mirum PharmaceuticalsSC 13D/A Apr 8, 2022 to Aug 18, 2022²⁸
• Checkmate PharmaceuticalsSC 13D/A Nov 1, 2021 to Jun 3, 2022²⁹
• Nkarta Therapeutics (United States)SC 13D/A Nov 22, 2021 to Jun 3, 2022³⁰
• Morphic Holding, Inc.SC 13D/A Nov 1, 2021 to Feb 22, 2022³¹